NTRK gene fusions can drive unregulated cell growth and proliferation in a range of cancer types. Recently, this pathway gained significant focus and attention in precision oncology.
Next-Generation Sequencing provides the most comprehensive view across a large number of genes and can identify NTRK gene fusions as well as other relevant alterations, with minimal sample tissue needed.
Introduction to NTRK Testing in 3 minutes – Download the Quick Reference guide
View this educational webinar to learn:
PD Dr. med. Spasenija Savic Prince
Institute for Medical Genetics and Pathology, University Hospital Basel, Switzerland
We offer several NGS-based, multibiomarker assays for clinical research designed to simultaneously detect gene fusions, such as NTRK1, NTRK2 and NTRK3, as well as hundreds of DNA and RNA-based genomic alterations associated with cancer. They include: Oncomine Comprehensive Assay, Oncomine Focus Assay, and the Oncomine Childhood Cancer Research Assay.
For Research Use Only. Not for use in diagnostic procedures.